These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 24070051)
1. Investigation into temperature-induced aggregation of an antibody drug conjugate. Beckley NS; Lazzareschi KP; Chih HW; Sharma VK; Flores HL Bioconjug Chem; 2013 Oct; 24(10):1674-83. PubMed ID: 24070051 [TBL] [Abstract][Full Text] [Related]
2. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates. Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158 [TBL] [Abstract][Full Text] [Related]
3. Auristatin antibody drug conjugate physical instability and the role of drug payload. Adem YT; Schwarz KA; Duenas E; Patapoff TW; Galush WJ; Esue O Bioconjug Chem; 2014 Apr; 25(4):656-64. PubMed ID: 24559399 [TBL] [Abstract][Full Text] [Related]
4. Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats. Boswell CA; Mundo EE; Zhang C; Bumbaca D; Valle NR; Kozak KR; Fourie A; Chuh J; Koppada N; Saad O; Gill H; Shen BQ; Rubinfeld B; Tibbitts J; Kaur S; Theil FP; Fielder PJ; Khawli LA; Lin K Bioconjug Chem; 2011 Oct; 22(10):1994-2004. PubMed ID: 21913715 [TBL] [Abstract][Full Text] [Related]
5. In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugate. Sanderson RJ; Hering MA; James SF; Sun MM; Doronina SO; Siadak AW; Senter PD; Wahl AF Clin Cancer Res; 2005 Jan; 11(2 Pt 1):843-52. PubMed ID: 15701875 [TBL] [Abstract][Full Text] [Related]
6. Characterization and Higher-Order Structure Assessment of an Interchain Cysteine-Based ADC: Impact of Drug Loading and Distribution on the Mechanism of Aggregation. Guo J; Kumar S; Chipley M; Marcq O; Gupta D; Jin Z; Tomar DS; Swabowski C; Smith J; Starkey JA; Singh SK Bioconjug Chem; 2016 Mar; 27(3):604-15. PubMed ID: 26829368 [TBL] [Abstract][Full Text] [Related]
7. Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues. Valliere-Douglass JF; McFee WA; Salas-Solano O Anal Chem; 2012 Mar; 84(6):2843-9. PubMed ID: 22384990 [TBL] [Abstract][Full Text] [Related]
8. Bridging disulfides for stable and defined antibody drug conjugates. Badescu G; Bryant P; Bird M; Henseleit K; Swierkosz J; Parekh V; Tommasi R; Pawlisz E; Jurlewicz K; Farys M; Camper N; Sheng X; Fisher M; Grygorash R; Kyle A; Abhilash A; Frigerio M; Edwards J; Godwin A Bioconjug Chem; 2014 Jun; 25(6):1124-36. PubMed ID: 24791606 [TBL] [Abstract][Full Text] [Related]
9. Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates. Liu-Shin L; Fung A; Malhotra A; Ratnaswamy G MAbs; 2018; 10(4):583-595. PubMed ID: 29436897 [TBL] [Abstract][Full Text] [Related]
10. High-Throughput Cysteine Scanning To Identify Stable Antibody Conjugation Sites for Maleimide- and Disulfide-Based Linkers. Ohri R; Bhakta S; Fourie-O'Donohue A; Dela Cruz-Chuh J; Tsai SP; Cook R; Wei B; Ng C; Wong AW; Bos AB; Farahi F; Bhakta J; Pillow TH; Raab H; Vandlen R; Polakis P; Liu Y; Erickson H; Junutula JR; Kozak KR Bioconjug Chem; 2018 Feb; 29(2):473-485. PubMed ID: 29425028 [TBL] [Abstract][Full Text] [Related]
12. Cathepsin B Cleavage of vcMMAE-Based Antibody-Drug Conjugate Is Not Drug Location or Monoclonal Antibody Carrier Specific. Gikanga B; Adeniji NS; Patapoff TW; Chih HW; Yi L Bioconjug Chem; 2016 Apr; 27(4):1040-9. PubMed ID: 26914498 [TBL] [Abstract][Full Text] [Related]